[ad_1]
The day before, the US Food and Drug Administration (FDA) announced that the Johnson & Johnson vaccine was highly effective in protecting against severe forms of coronavirus infection and COVID-19 mutations found in South Africa and Brazil.
Meriam Adhbi al Jalahma, head of Bahrain’s National Health Authority, said officials “thoroughly examined all the documents submitted by the company that contained the results of clinical trials.”
The Johnson & Johnson vaccine “provides excellent protection against the severe form of COVID-19,” the report adds.
AFP / “Scanpix” nuotr./ “Johnson & Johnson” vakcina nuo koronaviruso
Bahrain said the Johnson & Johnson vaccine will be vaccinated against the most vulnerable, including the elderly and the chronically ill. However, the government has not specified when these vaccines will be delivered to the country and when they will be used.
About 2 million The Chinese population already uses vaccines developed by the Chinese Sinopharm, the American and German Pfizer-BioNTech, the British and Swedish Oxford-AstraZeneca and the Russian Sputnik V.
In Bahrain, 119,858 cases of coronavirus infection were confirmed, including 437 deaths.
According to FDA documents released Wednesday, large-scale clinical trials showed the vaccine’s efficacy was 85.9 percent in the United States, 81.7 percent in South Africa, and 87.6 percent in Brazil. .
An independent group of experts from the US Food and Drug Administration will meet on Friday to discuss the benefits of the vaccine, and permission to distribute the vaccine in an emergency should be granted soon.
In addition to the US FDA, the European Medicines Agency (EVA) and the World Health Organization (WHO) are also considering approving the Johnson & Johnson vaccine. EVA is expected to approve the drug in mid-March.
The company aims to produce approximately one billion doses worldwide by the end of the year.
The Johnson & Johnson vaccine is based on a genetically modified cold-causing adenovirus that can no longer reproduce. It contains an important protein gene from the coronavirus that enters human cells.
This forces the cells to produce this protein and prepare the immune system to fight the virus.
A single dose of this vaccine is enough to build immunity. Additionally, this vaccine does not need to be stored at extremely low temperatures like the Pfizer and Moderna vaccines, making it easy to distribute.
[ad_2]
